BACKGROUND: Strong evidence has confirmed the benefit of laparoscopy in colorectal cancer resection but remains a challenging procedure. It is not clear that such promising results in selected patients translate into a favorable risk-benefit balance in real practice. We conducted a multicenter national observational registry to assess operative and oncologic long-term outcomes following laparoscopic colorectal cancer resection. METHODS: All patients with laparoscopic colorectal cancer resection between 2001 and 2004 were included. Data were extracted from the prospective Italian national database of 10 high-volume centers (≥40 colorectal cancer laparoscopic resections per year). Surgical technique and follow-up were standardized. Survivals were analyzed by Kaplan-Meier method. RESULTS: We reported 1832 patients with colon (58.5%) and rectal cancer (41.5%). TNM stage was 0-I-II in 1044 patients (57%) and III-IV in 788 patients (43%). Surgery included a totally laparoscopic procedure in 1820 patients (99.3%). Conversion was 10.5%. Postoperative morbidity and 30-day mortality rates were 17 and 1.2%, respectively. Clinical anastomotic leakage rate was 8.3% (n=152). R0 resection was 95%. With a median follow-up of 54.2 months, cancer recurrence rate was 13.3%. At 5 years, cancer-free survival was 86.7%. Upon multivariate analysis, age (P=0.001) and TNM stage (P<0.001) were associated with cancer-free survival. Predictive factors of cancer recurrence were gender (P=0.029) and TNM stage (P<0.001). CONCLUSIONS: In high-volume centers and non-selective patients, laparoscopic colorectal resection for cancer achieves good operative results with satisfactory long-term oncologic results. Even in the laparoscopy era, age, gender, and TNM stage remain the most powerful predictor of oncologic outcomes.
BACKGROUND: Strong evidence has confirmed the benefit of laparoscopy in colorectal cancer resection but remains a challenging procedure. It is not clear that such promising results in selected patients translate into a favorable risk-benefit balance in real practice. We conducted a multicenter national observational registry to assess operative and oncologic long-term outcomes following laparoscopic colorectal cancer resection. METHODS: All patients with laparoscopic colorectal cancer resection between 2001 and 2004 were included. Data were extracted from the prospective Italian national database of 10 high-volume centers (≥40 colorectal cancer laparoscopic resections per year). Surgical technique and follow-up were standardized. Survivals were analyzed by Kaplan-Meier method. RESULTS: We reported 1832 patients with colon (58.5%) and rectal cancer (41.5%). TNM stage was 0-I-II in 1044 patients (57%) and III-IV in 788 patients (43%). Surgery included a totally laparoscopic procedure in 1820 patients (99.3%). Conversion was 10.5%. Postoperative morbidity and 30-day mortality rates were 17 and 1.2%, respectively. Clinical anastomotic leakage rate was 8.3% (n=152). R0 resection was 95%. With a median follow-up of 54.2 months, cancer recurrence rate was 13.3%. At 5 years, cancer-free survival was 86.7%. Upon multivariate analysis, age (P=0.001) and TNM stage (P<0.001) were associated with cancer-free survival. Predictive factors of cancer recurrence were gender (P=0.029) and TNM stage (P<0.001). CONCLUSIONS: In high-volume centers and non-selective patients, laparoscopic colorectal resection for cancer achieves good operative results with satisfactory long-term oncologic results. Even in the laparoscopy era, age, gender, and TNM stage remain the most powerful predictor of oncologic outcomes.
Authors: Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer Journal: Lancet Oncol Date: 2008-12-13 Impact factor: 41.316
Authors: Thierry Bege; Bernard Lelong; Benjamin Esterni; Olivier Turrini; Jerôme Guiramand; Daniel Francon; Djamel Mokart; Gilles Houvenaeghel; Marc Giovannini; Jean Robert Delpero Journal: Ann Surg Date: 2010-02 Impact factor: 12.969
Authors: Erin M Siegel; Paul B Jacobsen; Mokenge Malafa; William Fulp; Michelle Fletcher; Ji-Hyun Lee; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata Journal: J Oncol Pract Date: 2012-06-12 Impact factor: 3.840
Authors: Kjartan Stormark; Kjetil Søreide; Jon Arne Søreide; Jan Terje Kvaløy; Frank Pfeffer; Morten T Eriksen; Bjørn S Nedrebø; Hartwig Kørner Journal: Surg Endosc Date: 2016-02-23 Impact factor: 4.584
Authors: Piera Leon; Michele Giuseppe Iovino; Fabiola Giudici; Antonio Sciuto; Nicolò de Manzini; Diego Cuccurullo; Francesco Corcione Journal: Surg Endosc Date: 2017-08-25 Impact factor: 4.584
Authors: Amit Merchea; Shahzad M Ali; Scott R Kelley; Emilie Duchalais; Jasim Y Alabbad; Eric J Dozois; David W Larson Journal: J Gastrointest Surg Date: 2018-03-28 Impact factor: 3.452
Authors: Madison M Wahlen; Mary C Schroeder; Erin C Johnson; Ingrid M Lizarraga; Jacklyn M Engelbart; David J Tatman; Cheyenne Wagi; Mary E Charlton; Sarah A Birken Journal: Front Health Serv Date: 2022-04-28
Authors: Michael P M de Neree Tot Babberich; Julia T van Groningen; Evelien Dekker; Theo Wiggers; Michel W J M Wouters; Willem A Bemelman; Pieter J Tanis Journal: Surg Endosc Date: 2018-01-17 Impact factor: 4.584